Details of the Drug

General Information of Drug (ID: DMMPD09)

Drug Name

T-121

Synonyms

DHLNQBGKTBJPSZ-SKPGKBGKSA-N; T121; H-Arg-Arg-Trp-Cys(x1)-Tyr-Arg-Lys-Lys-Gly-Tyr-Arg-Lys-Cys(x1)-Arg-OH

Indication

Disease Entry	ICD 11	Status	REF
Complex regional pain syndrome	8D8A.0	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C85H137N33O17S2
Canonical SMILES: C1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)NC(CCCNC(=N)N)C(=O)O)CCCCN)CCCNC(=N)N)CC2=CC=C(C=C2)O)CCCCN)CCCCN)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N
InChI: 1S/C85H137N33O17S2/c86-32-6-3-17-55-69(123)106-44-67(121)107-62(40-47-24-28-50(119)29-25-47)75(129)112-59(21-11-37-102-83(94)95)71(125)111-57(19-5-8-34-88)74(128)117-65(78(132)114-61(80(134)135)23-13-39-104-85(98)99)45-136-137-46-66(79(133)115-63(41-48-26-30-51(120)31-27-48)76(130)113-60(22-12-38-103-84(96)97)72(126)110-56(70(124)109-55)18-4-7-33-87)118-77(131)64(42-49-43-105-54-16-2-1-14-52(49)54)116-73(127)58(20-10-36-101-82(92)93)108-68(122)53(89)15-9-35-100-81(90)91/h1-2,14,16,24-31,43,53,55-66,105,119-120H,3-13,15,17-23,32-42,44-46,86-89H2,(H,106,123)(H,107,121)(H,108,122)(H,109,124)(H,110,126)(H,111,125)(H,112,129)(H,113,130)(H,114,132)(H,115,133)(H,116,127)(H,117,128)(H,118,131)(H,134,135)(H4,90,91,100)(H4,92,93,101)(H4,94,95,102)(H4,96,97,103)(H4,98,99,104)/t53-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-/m0/s1
InChIKey: DHLNQBGKTBJPSZ-SKPGKBGKSA-N

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)